title: The feasibility of universal influenza vaccination for infants and toddlers.
abstract: BACKGROUND
  Physicians' opinions on the feasibility of routine influenza vaccination of infants and toddlers are unknown.
  
  
  OBJECTIVE
  To assess the opinions of primary care providers regarding (1) the feasibility of an expanded influenza vaccination recommendation, (2) potential barriers, and (3) current and projected use of immunization reminder systems for influenza vaccination.
  
  
  METHODS
  In February 2001, we mailed a 20-item, self-administered survey to a national random sample of pediatricians and family physicians (FPs). The survey primarily focused on a scenario of routine influenza vaccination for children aged 12 through 35 months using either injected or intranasal spray vaccine.
  
  
  RESULTS
  Four hundred fifty-eight eligible physicians completed the survey (eligible response rate: pediatricians, 72%; FPs, 52%). Regarding the scenario mentioned above, most physicians agreed that implementation would be feasible (pediatricians, 80%; FPs, 69%); would significantly decrease illness visits during influenza season (pediatricians, 67%; FPs, 57%); and was justified by influenza's severity and complications (pediatricians, 61%; FPs, 41%). When considering a scenario that extended down to 6 months of age and only allowed use of injectable vaccine for infants, fewer physicians (pediatricians, 50%; FPs, 40%) considered implementation feasible. The issues most frequently cited as important potential barriers for practices were costs (77%), vaccine safety issues (52%), and the inability to identify eligible children (46%).
  
  
  CONCLUSIONS
  To make widespread implementation feasible, the following are needed: minimizing costs for families and physician practices, educational campaigns on key issues, and primary care system changes (eg, tracking of eligible children, reminder and/or recall systems, and immunization clinics).
authors.affiliation: New Vaccine Surveillance Network, Department of Rochester, 601 Elmwood Avenue, NY 14642, USA. sharon_humiston@urmc.rochester.edu
authors.forename: Sharon G
authors.initials: SG
authors.lastname: Humiston
authors.forename: Peter G
authors.initials: PG
authors.lastname: Szilagyi
authors.forename: Marika K
authors.initials: MK
authors.lastname: Iwane
authors.forename: Stanley J
authors.initials: SJ
authors.lastname: Schaffer
authors.forename: Jeanne
authors.initials: J
authors.lastname: Santoli
authors.forename: Laura
authors.initials: L
authors.lastname: Shone
authors.forename: Richard
authors.initials: R
authors.lastname: Barth
authors.forename: Thomas
authors.initials: T
authors.lastname: McInerny
authors.forename: Benjamin
authors.initials: B
authors.lastname: Schwartz
mesh_terms: D001071:Appointments and Schedules; D001291:Attitude of Health Personnel; D002669:Child Welfare; D002675:Child, Preschool; D003625:Data Collection; D005240:Feasibility Studies; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006284:Health Plan Implementation; D006801:Humans; D007223:Infant; D007229:Infant Welfare; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D015999:Multivariate Analysis; D009819:Office Visits; D010287:Parent-Child Relations; D010821:Physicians, Family; D010818:Practice Patterns, Physicians'; D017010:Reminder Systems; D014481:United States / Q000453:epidemiology; D014611:Vaccination
chemical_list: D007252:Influenza Vaccines